Insmed, Inc. (INSM)
109.53
+1.62
(+1.50%)
USD |
NASDAQ |
May 21, 16:00
109.60
+0.07
(+0.06%)
After-Hours: 19:59
Insmed Research and Development Expense (TTM) : 828.00M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 451.53M |
| ACADIA Pharmaceuticals, Inc. | 327.40M |
| PTC Therapeutics, Inc. | 447.15M |
| Revolution Medicines, Inc. | 1.117B |
| United Therapeutics Corp. | 539.20M |